As of April 16, 2025, LENZ Therapeutics (LENZ) has a market cap of $0.66 billion USD. According to our data, LENZ Therapeutics is ranked No.5615 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.66 B |
-17.12%
|
Dec 31, 2024 | $0.79 B |
711.22%
|
Dec 29, 2023 | $97.87 M |
-21.08%
|
Dec 30, 2022 | $0.12 B |
-73.29%
|
Dec 31, 2021 | $0.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
![]() USA
|
![]() Kala Pharmaceuticals
KALA
|
$22.78 M |
0.000 M
|
![]() USA
|
![]() Aldeyra Therapeutics
ALDX
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Ocuphire Pharma
OCUP
|
$31.74 M |
4.753 M
|
![]() USA
|
![]() Alimera Sciences
ALIM
|
$0.30 B |
0.000 M
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Apellis Pharmaceuticals
APLS
|
$2.38 B |
-0.000 M
|
![]() USA
|
![]() Kodiak Sciences
KOD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Outlook Therapeutics
OTLK
|
$45.34 M |
-0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
Market Cap | = | LENZ Stock Price | * | LENZ Shares Outstanding |
= | $23.89 | * | 27.54 M | |
= | $0.66 B |